MTOR and breast cancer: In addition, PPARγ activation promotes the expression of its target gene PTEN to inhibit the PI3K/AKT/mTOR signaling, thereby suppressing the proliferation of breast cancer cells and the tumorigenicity and metastasis of cervical, glioblastoma, and liver cancer stem cells.52